In 2024, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) received more than * applications for drug approvals, representing a slight increase of *** percent from the previous year. Most of the drugs submitted for evaluation were subjected to technical reviews.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
National Medical Products Administration. (March 18, 2025). Number of applications for drug evaluations submitted in China from 2018 to 2024, by category [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/1319462/china-number-of-drug-evaluation-applications-submitted/
National Medical Products Administration. "Number of applications for drug evaluations submitted in China from 2018 to 2024, by category." Chart. March 18, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/1319462/china-number-of-drug-evaluation-applications-submitted/
National Medical Products Administration. (2025). Number of applications for drug evaluations submitted in China from 2018 to 2024, by category. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/1319462/china-number-of-drug-evaluation-applications-submitted/
National Medical Products Administration. "Number of Applications for Drug Evaluations Submitted in China from 2018 to 2024, by Category." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 18 Mar 2025, /statistics/1319462/china-number-of-drug-evaluation-applications-submitted/
National Medical Products Administration, Number of applications for drug evaluations submitted in China from 2018 to 2024, by category ÌÇÐÄÆƽâ°æ, /statistics/1319462/china-number-of-drug-evaluation-applications-submitted/ (last visited July 29, 2026)
Number of applications for drug evaluations submitted in China from 2018 to 2024, by category [Graph], National Medical Products Administration, March 18, 2025. [Online]. Available: /statistics/1319462/china-number-of-drug-evaluation-applications-submitted/
